Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

INTERIM MANAGEMENT STATEMENT

9 Nov 2023 09:54

RNS Number : 9440S
Mandarin Oriental International Ltd
09 November 2023

Announcement

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

9th November 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2023.

Global luxury travel demand remained buoyant in the period, contributing to a strong performance across the business. Underlying profit in the third quarter was more than double the level seen in the same period in 2022. The increase was driven by higher fee income in the Management Business and improved earnings from Owned Hotels - particularly Hong Kong and Tokyo.

Revenue per Available Room ('RevPAR') in Europe, the Middle East and Africa grew in the period compared to the third quarter of 2022, predominantly driven by rates, whilst Asia achieved a substantial improvement in RevPAR driven by both rates and occupancy. In America, RevPAR remained broadly flat. The Group's combined RevPAR was substantially ahead of pre-pandemic levels in the third quarter, driven by rates, but occupancy remained behind those levels.

In August, the Group opened its first hotel in Greece - Mandarin Oriental, Costa Navarino. In September, Mandarin Oriental, Singapore reopened its doors to guests with a transformed offering after a six-month renovation. In the third quarter, the Group announced a new management contract for a luxury resort in Porto Cervo, Sardinia, marking its fourth venture in Italy. The Group expects to open Mandarin Oriental Savoy, Zurich by the end of the year.

Consolidated net debt as at 30th September 2023 reduced to US$219 million (US$233 million at 30th June 2023). The Group's liquidity position remains robust, with US$496 million in available committed debt facilities and US$355 million of cash reserves. Gearing was 5% of adjusted shareholders' funds.

Further to the Company's announcement on 2nd May 2023, the Group welcomes the assumption by Laurent Kleitman of the role of Group Chief Executive with effect from 1st September 2023. Laurent has many years' experience of leading the creation and evolution of new and historic brands, as well as growth strategies focussed on customer-centric innovation and experience.

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

- end -

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

Max Fleming

Director of Corporate Finance (852) 2895 9171

Chris Orlikowski

Director of Global Communications (44) 791 7280 210

Brunswick Group Limited

William Brocklehurst (852) 5685 9881

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DOCKKLBBXFLEFBF
Date   Source Headline
8th Apr 20221:02 pmRNSCorrection: TRANS Date-Director/PDMR Shareholding
7th Apr 202210:28 amRNSAnnual Financial Report
4th Apr 20221:12 pmRNSDirector/PDMR Shareholding
31st Mar 20221:18 pmRNSTotal Voting Rights
30th Mar 202210:58 amRNSCirc re. Scrip Dividend Scheme
25th Mar 202211:50 amRNSBlock listing Interim Review
25th Mar 202211:24 amRNSDirector/PDMR Shareholding
23rd Mar 202212:27 pmRNSDirector/PDMR Shareholding
15th Mar 20229:27 amRNSDirector/PDMR Shareholding
4th Mar 202210:30 amRNSTransaction in Own Shares
3rd Mar 202211:22 amRNSTransaction in Own Shares
3rd Mar 202210:27 amRNS2021 Preliminary Announcement of Results
3rd Mar 20229:33 amRNS2021 Preliminary Announcement of Results
3rd Mar 20229:32 amRNSDirectorate Change
3rd Mar 20229:30 amRNS2021 Preliminary Announcement of Results
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
2nd Mar 20221:12 pmRNSTransaction in Own Shares
2nd Mar 202210:43 amRNSPT Hero Supermarket Tbk Full Year 2021 Results
1st Mar 202211:28 amRNSTransaction in Own Shares
28th Feb 202212:27 pmRNSJC&C - 2021 FY Results & Dividend
28th Feb 202211:13 amRNSTotal Voting Rights
28th Feb 202211:06 amRNSTransaction in Own Shares
28th Feb 202210:46 amRNS2021 Financial Statements & Dividend Announcement
25th Feb 20221:04 pmRNSTransaction in Own Shares
25th Feb 20229:50 amRNSPT Astra International Tbk (Astra) - FY Results
24th Feb 202210:56 amRNSTransaction in Own Shares
23rd Feb 202210:24 amRNSTransaction in Own Shares
22nd Feb 202210:24 amRNSTransaction in Own Shares
21st Feb 202210:40 amRNSTransaction in Own Shares
18th Feb 202211:38 amRNSTransaction in Own Shares
16th Feb 202211:16 amRNSTransaction in Own Shares
15th Feb 202210:09 amRNSTransaction in Own Shares
14th Feb 202210:49 amRNSTransaction in Own Shares
11th Feb 202210:09 amRNSTransaction in Own Shares
10th Feb 202211:42 amRNSTransaction in Own Shares
9th Feb 202210:14 amRNSTransaction in Own Shares
7th Feb 202210:32 amRNSTransaction in Own Shares
4th Feb 202210:18 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSDirector/PDMR Shareholding
31st Jan 20228:19 amRNSTotal Voting Rights
31st Jan 20227:53 amRNSTransaction in Own Shares
28th Jan 202211:19 amRNSTransaction in Own Shares
27th Jan 202212:51 pmRNSDirector/PDMR Shareholding
27th Jan 202211:28 amRNSTransaction in Own Shares
26th Jan 202210:29 amRNSTransaction in Own Shares
25th Jan 202210:38 amRNSTransaction in Own Shares
24th Jan 202210:42 amRNSTransaction in Own Shares
21st Jan 202212:02 pmRNSShare repurchase etc
20th Jan 202211:27 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.